These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3013065)

  • 1. Recent studies on opioid receptors: heterogeneity and purification.
    Simon EJ
    Ann N Y Acad Sci; 1986; 463():31-45. PubMed ID: 3013065
    [No Abstract]   [Full Text] [Related]  

  • 2. Endogenous ligands for sigma opioid receptors in the brain ("sigmaphin"): evidence from binding assays.
    Su TP; Weissman AD; Yeh SY
    Life Sci; 1986 Jun; 38(24):2199-210. PubMed ID: 3012236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of a kappa-opioid receptor subtype from frog brain.
    Simon J; Benyhe S; Hepp J; Khan A; Borsodi A; Szücs M; Medzihradszky K; Wollemann M
    Neuropeptides; 1987 Jul; 10(1):19-28. PubMed ID: 2890119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S; Pasternak GW
    Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL; Brown SR; Puttfarcken P; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin.
    Liebmann C; Schrader U; Brantl V
    Eur J Pharmacol; 1989 Aug; 166(3):523-6. PubMed ID: 2553436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL; Zarr GD; Brown SR; Cox BM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for an endogenous peptide ligand for the phencyclidine receptor.
    Quirion R; DiMaggio DA; French ED; Contreras PC; Shiloach J; Pert CB; Everist H; Pert A; O'Donohue TL
    Peptides; 1984; 5(5):967-73. PubMed ID: 6095223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and characterization of four binding sites for opioids in the mouse brain.
    Neil A
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):108-16. PubMed ID: 2986409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity [3H]ethylketazocine binding: evidence for specific kappa receptors.
    Wood PL; Charleson S
    Neuropharmacology; 1982 Mar; 21(3):215-9. PubMed ID: 6122185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro.
    Garzón J; Jen MF; Sánchez-Blázquez P; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1789-92. PubMed ID: 6130441
    [No Abstract]   [Full Text] [Related]  

  • 17. Traumatic injury alters opiate receptor binding in rat spinal cord.
    Krumins SA; Faden AI
    Ann Neurol; 1986 May; 19(5):498-501. PubMed ID: 3013077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of kappa-opioid receptor subtype from frog brain.
    Simon J; Benyhe S; Borsodi A; Szücs M; Wollemann M
    FEBS Lett; 1985 Apr; 183(2):395-7. PubMed ID: 2985433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a kappa-opioid receptor on pituitary astrocytes: an autoradiographic study.
    Bunn SJ; Hanley MR; Wilkin GP
    Neurosci Lett; 1985 Apr; 55(3):317-23. PubMed ID: 2989733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.